Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Mirati Therapeutics (MRTX)

$92.13 2.01 (2.23%)

17:58 EDT MRTX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $92.13

Market Cap 2.97B

PE Ratio -35.95

EPS -2.562953

Volume (Avg. Vol.) 317,300

Day's Range 90.45 - 93.76

52-Week Range 28.50 - 111.99

Dividend & Yield N/A (N/A)

MRTX Stock Predictions, Articles, and Mirati Therapeutics News

From InvestorPlace
From the Web

The 10 Best Stocks for 2019 — So Far

By James Brumley, InvestorPlace Feature Writer Jun 4, 2019

Roku, Array Biopharma and Guardant Health are just some of the best stocks by returns for the first half of 2019.

Mirati Therapeutics (MRTX) Gets a Buy Rating from H.C. Wainwright

From Smarter Analyst Aug 6, 2019

H.C. Wainwright analyst Edward White maintained a Buy rating on Mirati Therapeutics (MRTX) today and set a price target of $117. The company's shares

Mirati Therapeutics (MRTX) Gets a Buy Rating from H.C. Wainwright

From Analyst Ratings Aug 6, 2019

H.C. Wainwright analyst Edward White maintained a Buy rating on Mirati Therapeutics (MRTX – Research Report) today and set a price target of $117. The company’s shares closed yesterday at $93.65. White observed: “Our $117 price target is based on a sum-of-the-parts analysis determined by probability adjusted revenue forecasts for sitravatinib and MRTX849. We use

Mirati Therapeutics (MRTX) Gets a Buy Rating from Cowen & Co.

From Smarter Analyst Aug 6, 2019

Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Mirati Therapeutics (MRTX) yesterday. The company's shares closed yesterday at $93.65.

Mirati Therapeutics (MRTX) Gets a Buy Rating from Cowen & Co.

From Analyst Ratings Aug 6, 2019

Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Mirati Therapeutics (MRTX – Research Report) yesterday. The company’s shares closed yesterday at $93.65. According to TipRanks.com, Shibutani is a 4-star analyst with an average return of 5.2% and a 38.7% success rate. Shibutani covers the Healthcare sector, focusing on stocks such as Syndax

Best & Worst Performing Mid Cap Stocks for August 2, 2019

From StockNews.com Aug 2, 2019

BL – BL leads the way today as the best performing mid cap stock, closing up 31.66%.

Immersion, Acacia, Mirum, and Other 13D Filings

From Barron's Aug 2, 2019

Red Robin Gourmet Burgers is in the Activist Spotlight, under pressure to begin an auction of the company.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!